Table 1.
Clinical characteristics of low and high ITPKC expression in TNBC patients in the TCGA cohort.
| Clinical Variables | ITPKC-Low | ITPKC-High | p-Value |
|---|---|---|---|
| (n = 119) | (n = 40) | ||
| Age at diagnosis | 0.920 | ||
| Median | 55.0 | 52.5 | |
| IQR | 48–62 | 44–66 | |
| Race | 0.078 | ||
| White | 75 (63.0%) | 15 (37.5%) | |
| Black | 29 (24.4%) | 25 (62.5%) | |
| Asian | 8 (6.7%) | 0 (0%) | |
| AJCC T-category | 0.116 | ||
| T1 | 28 (23.5%) | 12 (30.0%) | |
| T2 | 79 (66.4%) | 20 (50.0%) | |
| T3 | 10 (8.4%) | 5 (12.5%) | |
| T4 | 2 (1.7%) | 3 (7.5%) | |
| AJCC N-category | 0.440 | ||
| N- | 81 (68.1%) | 24 (60.0%) | |
| N+ | 38 (31.9%) | 16 (40.0%) | |
| AJCC M-category | 0.405 | ||
| M- | 104 (87.4%) | 30 (75.0%) | |
| M+ | 1 (0.8%) | 1 (2.5%) | |
| Stage at diagnosis | 0.078 | ||
| I | 20 (16.8%) | 8 (20.0%) | |
| II | 82 (68.9%) | 20 (50.0%) | |
| III | 14 (11.8%) | 10 (25.0%) | |
| IV | 1 (0.8%) | 1 (2.5%) |
AJCC: American Joint Committee on Cancer, IQR: interquartile range.